The biotech sector has underperformed the market for many years now, but there are reasons to be optimistic. Click here for ...
Stock market crashes are scary, but they've always been followed by longer recovery periods. Intuitive Surgical is a leading ...
BioCryst Pharmaceuticals, Inc. acquires Astria Therapeutics for ~$700M, aiming to bolster its HAE portfolio. Learn more about ...
BioCryst Pharmaceuticals said on Tuesday it would buy Astria Therapeutics in a cash-and-stock deal valued at about $700 ...
These companies are investing heavily into their pipelines and the payoff for long-term investors can be substantial.
Recently, there have been concerns around the surge of fraudulent loans and private credit quality issues in the US.
Shares of mid-cap oncology specialist Exelixis are worth about $39 each right now. The biotech generates steady revenue and ...
CRMD, CELC, RANI, and RAPT are pushing aggressively to the upside on Monday. Here's what is driving these four biotech stocks ...
Over the past decade, pharmaceutical maker Pfizer ( PFE -0.53%) has severely lagged the market. Dividends reinvested aside, ...
The pharmaceutical company has also earned approval for Wegovy in treating metabolic dysfunction-associated steatohepatitis ...
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is one of the best healthcare stocks with the highest upside. In a report ...
Aurobindo Pharma stock analysis with support, resistance levels, F&O pointers, and trading strategy for potential profit.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results